Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 9Thoracic 5Sarcoma 2Other hematologic neoplasm 2Gynecologic 2Genitourinary 2CNS 2NET 1Lymphoid 1Endocrine 1

Conditions

Sarcoma 437Osteosarcoma 131Sarcoma, Ewing 89Melanoma 81Rhabdomyosarcoma 78Neoplasms 70Gastrointestinal Stromal Tumors 63Neuroblastoma 62Bone Neoplasms 62Colorectal Neoplasms 60Breast Neoplasms 60Ovarian Neoplasms 58Glioblastoma 55Neoplasm Metastasis 52Liposarcoma 49Dendritic Cell Sarcoma, Interdigitating 46Carcinoma, Non-Small-Cell Lung 44Gliosarcoma 42Stomach Neoplasms 41Leiomyosarcoma 41Pancreatic Neoplasms 40Lymphoma 37Glioma 35Carcinoma, Renal Cell 35Sarcoma, Synovial 34Rhabdoid Tumor 34Neurofibrosarcoma 34Uterine Cervical Neoplasms 33Sarcoma, Kaposi 33Lymphoma, Non-Hodgkin 33

Interventions

pimonidazole 1fluoroazomycin arabinoside 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hypoxia × Sarcoma × 1 year × Clear all
NCT06476704 2026-06-04

PRACTISS

Centre Paul Strauss

Phase 2 Not yet recruiting
42 enrolled
Sarcoma

Hypoxia, Sarcoma

NCT03418818 2026-03-06

FAZA PET/MRI Sarcoma

University Health Network, Toronto

Phase NA Active not recruiting
70 enrolled
Sarcoma

Hypoxia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡